China Healthwise Holdings Limited (HKG:0348)
Hong Kong · Delayed Price · Currency is HKD 0.1300
-0.0010 (-0.76%)
Jan 28, 2026, 3:29 PM HKT
China Healthwise Holdings Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 103.7 | 113.58 | 146.32 | 142.06 | 170.08 | 137.85 | Upgrade | |
Revenue Growth (YoY) | -17.97% | -22.38% | 3.00% | -16.48% | 23.38% | -4.19% | Upgrade |
Cost of Revenue | 63.16 | 78.58 | 193.49 | 113.57 | 181.69 | 125.49 | Upgrade |
Gross Profit | 40.54 | 35 | -47.18 | 28.49 | -11.61 | 12.36 | Upgrade |
Selling, General & Admin | 44.53 | 55.45 | 65.4 | 66.87 | 64.17 | 64.67 | Upgrade |
Operating Expenses | 44.53 | 55.45 | 65.4 | 66.87 | 64.17 | 64.67 | Upgrade |
Operating Income | -3.99 | -20.45 | -112.58 | -38.39 | -75.79 | -52.31 | Upgrade |
Interest Expense | -10.41 | -8.3 | -8.99 | -7.3 | -6.41 | -18.85 | Upgrade |
Interest & Investment Income | - | - | - | - | - | 0.01 | Upgrade |
Other Non Operating Income (Expenses) | 0.02 | 0.01 | 0.18 | 0.7 | 0 | 5.8 | Upgrade |
EBT Excluding Unusual Items | -14.38 | -28.74 | -121.39 | -44.98 | -82.19 | -65.35 | Upgrade |
Gain (Loss) on Sale of Investments | 13.25 | -4.19 | -10.34 | -15.33 | -15.3 | -5.41 | Upgrade |
Asset Writedown | -2.24 | -0.8 | -0.32 | -0.62 | -3.24 | -3.03 | Upgrade |
Other Unusual Items | -6.3 | -6.3 | - | 4.53 | 0.15 | 0.86 | Upgrade |
Pretax Income | -9.66 | -40.03 | -132.06 | -56.4 | -100.58 | -72.93 | Upgrade |
Income Tax Expense | 0.54 | 0.25 | 2.5 | -2.13 | 2.47 | -3.65 | Upgrade |
Earnings From Continuing Operations | -10.2 | -40.28 | -134.56 | -54.27 | -103.05 | -69.28 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | - | 44.06 | Upgrade |
Net Income to Company | -10.2 | -40.28 | -134.56 | -54.27 | -103.05 | -25.22 | Upgrade |
Net Income | -10.2 | -40.28 | -134.56 | -54.27 | -103.05 | -25.22 | Upgrade |
Net Income to Common | -10.2 | -40.28 | -134.56 | -54.27 | -103.05 | -25.22 | Upgrade |
Shares Outstanding (Basic) | 770 | 770 | 770 | 770 | 770 | 775 | Upgrade |
Shares Outstanding (Diluted) | 770 | 770 | 770 | 770 | 770 | 775 | Upgrade |
Shares Change (YoY) | - | - | - | - | -0.58% | -4.42% | Upgrade |
EPS (Basic) | -0.01 | -0.05 | -0.17 | -0.07 | -0.13 | -0.03 | Upgrade |
EPS (Diluted) | -0.01 | -0.05 | -0.17 | -0.07 | -0.13 | -0.03 | Upgrade |
Free Cash Flow | 5.39 | 3.12 | 14.3 | -28.97 | 41.72 | 7.47 | Upgrade |
Free Cash Flow Per Share | 0.01 | 0.00 | 0.02 | -0.04 | 0.05 | 0.01 | Upgrade |
Gross Margin | 39.09% | 30.82% | -32.24% | 20.05% | -6.83% | 8.97% | Upgrade |
Operating Margin | -3.84% | -18.01% | -76.94% | -27.02% | -44.56% | -37.95% | Upgrade |
Profit Margin | -9.84% | -35.47% | -91.96% | -38.21% | -60.59% | -18.30% | Upgrade |
Free Cash Flow Margin | 5.20% | 2.75% | 9.77% | -20.39% | 24.53% | 5.42% | Upgrade |
EBITDA | -3.71 | -20.12 | -112.2 | -38.2 | -75.48 | -50.75 | Upgrade |
EBITDA Margin | -3.57% | -17.72% | -76.68% | -26.89% | -44.38% | -36.81% | Upgrade |
D&A For EBITDA | 0.28 | 0.33 | 0.38 | 0.18 | 0.31 | 1.56 | Upgrade |
EBIT | -3.99 | -20.45 | -112.58 | -38.39 | -75.79 | -52.31 | Upgrade |
EBIT Margin | -3.84% | -18.01% | -76.94% | -27.02% | -44.56% | -37.95% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.